NEW YORK (GenomeWeb News) – A class action lawsuit has been filed in federal court alleging Atossa Genetics violated federal securities laws.

In a complaint filed in the US District Court for the Western District of Washington on Thursday, plaintiff Nicholas Cook alleges Atossa made false and/or misleading statements and failed to disclose material adverse facts about its business and financial conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.